Hillsdale Investment Management Inc. boosted its holdings in shares of Genpact Limited (NYSE:G – Free Report) by 42.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 97,220 shares of the business services provider’s stock after purchasing an additional 28,800 shares during the quarter. Hillsdale Investment Management Inc. owned approximately 0.06% of Genpact worth $4,548,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Qsemble Capital Management LP acquired a new position in shares of Genpact during the fourth quarter valued at approximately $3,258,000. JPMorgan Chase & Co. increased its holdings in shares of Genpact by 17.1% in the third quarter. JPMorgan Chase & Co. now owns 3,762,407 shares of the business services provider’s stock valued at $157,609,000 after purchasing an additional 549,117 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Genpact by 36.3% in the third quarter. Principal Financial Group Inc. now owns 497,105 shares of the business services provider’s stock valued at $20,824,000 after purchasing an additional 132,310 shares during the last quarter. Envestnet Asset Management Inc. increased its stake in Genpact by 64.3% during the third quarter. Envestnet Asset Management Inc. now owns 533,566 shares of the business services provider’s stock worth $22,351,000 after acquiring an additional 208,762 shares during the last quarter. Finally, ProShare Advisors LLC increased its stake in Genpact by 27.5% during the third quarter. ProShare Advisors LLC now owns 153,260 shares of the business services provider’s stock worth $6,420,000 after acquiring an additional 33,056 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.
Insider Activity at Genpact
In other news, CEO Balkrishan Kalra sold 2,800 shares of the business’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $40.77, for a total transaction of $114,156.00. Following the sale, the chief executive officer owned 525,007 shares of the company’s stock, valued at $21,404,535.39. The trade was a 0.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.58% of the stock is owned by company insiders.
Genpact Price Performance
Genpact (NYSE:G – Get Free Report) last announced its quarterly earnings data on Tuesday, March 31st. The business services provider reported $0.98 earnings per share for the quarter. The company had revenue of $1.30 billion for the quarter. Genpact had a return on equity of 22.70% and a net margin of 11.04%. Research analysts anticipate that Genpact Limited will post 3.64 earnings per share for the current year.
Genpact Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be paid a dividend of $0.1875 per share. The ex-dividend date of this dividend is Wednesday, June 10th. This represents a $0.75 annualized dividend and a dividend yield of 2.3%. Genpact’s payout ratio is 23.01%.
Analyst Upgrades and Downgrades
Several research firms have issued reports on G. Susquehanna cut their target price on Genpact from $42.00 to $37.00 and set a “neutral” rating for the company in a research note on Tuesday, May 5th. Robert W. Baird decreased their target price on Genpact from $54.00 to $45.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Citigroup decreased their price target on Genpact from $43.00 to $35.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Needham & Company LLC reiterated a “buy” rating and set a $50.00 target price on shares of Genpact in a research report on Friday, May 8th. Finally, Wall Street Zen cut Genpact from a “buy” rating to a “hold” rating in a research report on Saturday, March 14th. One equities research analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $43.29.
View Our Latest Stock Report on Genpact
Genpact Company Profile
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
See Also
- Five stocks we like better than Genpact
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
